3 news items
Paladin Labs Announces Approval of WAKIX® (pitolisant hydrochloride tablets) For Use in Pediatric Patients in Canada
ENDPQ
28 Mar 24
Litigation Reform Act of 1995 and the relevant Canadian securities legislation. Statements including words such as "believes," "expects
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
ENDPQ
26 Mar 24
"forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities
Endo Announces Confirmation of Plan of Reorganization
ENDPQ
19 Mar 24
all of the Company's prior litigation overhang.
Additional resources for customers, suppliers
- Prev
- 1
- Next